MedTrace Logo

Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion

NCT02726971 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2017-04-10

Study results available
· View outcomes & findings →

Summary

This single-center,prospective,randomized,controlled trial is conducted to evaluate the efficacy of different doses of estrogen artificial periodic therapy after hysteroscopic adhesiolysis in patients with moderate-severe adhesion.

Conditions

  • Asherman Syndrome

Interventions

DRUG

Femoston

Femoston is a Complex Packing Estradiol Tablets and Estradiol and Dydrogesterone.

Sponsors & Collaborators

  • Fu Xing Hospital, Capital Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02726971 on ClinicalTrials.gov